Huibo Wang
Impact in
- Cancer Research top 5%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
- Molecular Biology top 10%
- DNA Repair Mechanisms
- RNA modifications and cancer
- Circular RNAs in diseases
- Ubiquitin and proteasome pathways
- Epigenetics and DNA Methylation
Papers in
-
- DNA Repair Mechanisms 9
- Ubiquitin and proteasome pathways 7
- RNA Research and Splicing 3
-
- Cancer, Hypoxia, and Metabolism 7
- MicroRNA in disease regulation 4
- Cancer-related molecular mechanisms research 4
- Co-authors
- Daru Lu (8 shared papers)Zhengxin Chen (11 shared papers)Wenting Wu (7 shared papers)Jia‐Cheng Lu (7 shared papers)Yongping You (6 shared papers)Ligang Fan (5 shared papers)Xiaomin Cai (3 shared papers)Ning Liu (5 shared papers)
- Journals
- Neuro-Oncology (3 papers)Carcinogenesis (2 papers)Journal of Clinical Investigation (2 papers)Oncotarget (2 papers)Molecular Therapy (1 paper)
- Partner nations
- ChinaUnited StatesSweden
In The Last Decade
Huibo Wang
31 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 95
- Cancer Research 466
- Molecular Biology 834
- Genetics 121
- Oncology 214
- Pathology and Forensic Medicine 90
Countries citing papers authored by Huibo Wang
This map shows the geographic impact of Huibo Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Huibo Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Huibo Wang more than expected).
Fields of papers citing papers by Huibo Wang
This network shows the impact of papers produced by Huibo Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Huibo Wang. The network helps show where Huibo Wang may publish in the future.
Co-authors
The 25 scholars most cited alongside Huibo Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 32 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 96 | |
| 2 | 2010 | 75 | |
| 3 | 2019 | 75 | |
| 4 | 2014 | 73 | |
| 5 | 2009 | 62 | |
| 6 | 2009 | 61 | |
| 7 | 2020 | 54 | |
| 8 | 2022 | 49 | |
| 9 | 2013 | 49 | |
| 10 | 2016 | 48 | |
| 11 | 2014 | 43 | |
| 12 | 2019 | 42 | |
| 13 | 2009 | 41 | |
| 14 | 2019 | 39 | |
| 15 | 2016 | 34 | |
| 16 | 2012 | 33 | |
| 17 | 2009 | 25 | |
| 18 | 2010 | 24 | |
| 19 | 2022 | 23 | |
| 20 | 2016 | 23 |
About Huibo Wang
Huibo Wang is a scholar working on Molecular Biology, Cancer Research, Genetics, Oncology and Epidemiology, having authored 32 papers that have together received 1.1k indexed citations. Recurring topics across this work include DNA Repair Mechanisms (9 papers), Glioma Diagnosis and Treatment (8 papers), Cancer, Hypoxia, and Metabolism (7 papers), Ubiquitin and proteasome pathways (7 papers), MicroRNA in disease regulation (4 papers), Cancer-related molecular mechanisms research (4 papers), RNA Research and Splicing (3 papers) and Microtubule and mitosis dynamics (3 papers). The work is most often cited by research in Cancer Research (466 citations), Molecular Biology (834 citations), Genetics (121 citations), Oncology (214 citations) and Pathology and Forensic Medicine (90 citations). Huibo Wang has collaborated with scholars based in China, United States and Sweden. Frequent co-authors include Daru Lu, Zhengxin Chen, Wenting Wu, Jia‐Cheng Lu, Yongping You, Ligang Fan, Xiaomin Cai, Ning Liu, Shuyu Zhang and Yuanyuan Chen. Their work appears in journals such as Neuro-Oncology, Carcinogenesis, Journal of Clinical Investigation, Oncotarget and Molecular Therapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.